Lifecore Biomedical, Inc. De (LFCR) Tax Provisions (2010 - 2025)

Lifecore Biomedical has reported Tax Provisions for 16 years, with the latest figure at $33000.0 in Q2 2025.

• On a quarterly basis, Tax Provisions rose 157.89% year-over-year to $33000.0 in Q2 2025; TTM through May 2025 was $43000.0, a 76.5% decrease from a year earlier, with the FY2025 full-year figure at $43000.0, down 76.5% from the prior year.
• Tax Provisions was $33000.0 for Q2 2025 at Lifecore Biomedical, up from -$8000.0 in the prior quarter.
• The five-year high for Tax Provisions was $3.4 million in Q1 2022, with the low at -$6.3 million in Q4 2021.
• Average Tax Provisions over 5 years is -$590277.8, with a median of $4000.0 recorded in 2022.
• The largest YoY upside for Tax Provisions was 2100.0% in 2023 against a maximum downside of 1725.0% in 2023.
• Over 5 years, Tax Provisions stood at -$6.3 million in 2021, then soared by 100.06% to $4000.0 in 2022, then slumped by 1725.0% to -$65000.0 in 2023, then soared by 166.15% to $43000.0 in 2024, then fell by 23.26% to $33000.0 in 2025.
• The last three Tax Provisions figures came in at $33000.0 (Q2 2025), -$8000.0 (Q1 2025), and $43000.0 (Q4 2024), per Business Quant data.